These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17500380)

  • 1. Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%.
    Colón LE; Johnson LA; Gottschalk RW
    Cutis; 2007 Apr; 79(4):317-21. PubMed ID: 17500380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
    Elewski BE; Fleischer AB; Pariser DM
    Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.
    Wolf JE; Kerrouche N; Arsonnaud S
    Cutis; 2006 Apr; 77(4 Suppl):3-11. PubMed ID: 16706244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin.
    Ziel K; Yelverton CB; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2005; 4(6):727-31. PubMed ID: 16302558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.
    Maddin S
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):961-5. PubMed ID: 10365928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):s101-7. PubMed ID: 25607798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azelaic acid (15% gel) in the treatment of acne rosacea.
    Gupta AK; Gover MD
    Int J Dermatol; 2007 May; 46(5):533-8. PubMed ID: 17472690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azelaic acid 15% gel: in the treatment of papulopustular rosacea.
    Frampton JE; Wagstaff AJ
    Am J Clin Dermatol; 2004; 5(1):57-64. PubMed ID: 14979745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A look at the safety of metronidazole 1% gel: cumulative irritation, contact sensitization, phototoxicity, and photoallergy potential.
    Beutner KR; Lemke S; Calvarese B
    Cutis; 2006 Apr; 77(4 Suppl):12-7. PubMed ID: 16706245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea.
    Del Rosso JQ; Bruce S; Jarratt M; Menter A; Staedtler G
    J Drugs Dermatol; 2010 Jun; 9(6):607-13. PubMed ID: 20645521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application.
    Del Rosso JQ; Bhatia N
    Cutis; 2011 Aug; 88(2):67-72. PubMed ID: 21916272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 15% azelaic acid gel and 0.75% metronidazole gel for the topical treatment of papulopustular rosacea.
    Czernielewski J; Liu Y
    Arch Dermatol; 2004 Oct; 140(10):1282-3; author reply 1283. PubMed ID: 15492198
    [No Abstract]   [Full Text] [Related]  

  • 13. Rosacea trial comparing twice-daily azelaic acid gel 15% with once-daily metronidazole gel 1%.
    Elewski BE
    Cutis; 2007 Jan; 79(1):57-8; author reply 58. PubMed ID: 17330623
    [No Abstract]   [Full Text] [Related]  

  • 14. Noxious sensory perceptions in patients with mild to moderate rosacea treated with azelaic acid 15% gel.
    Draelos ZD
    Cutis; 2004 Oct; 74(4):257-60. PubMed ID: 15551720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
    Draelos ZD; Colón LE; Preston N; Johnson LA; Gottschalk RW
    Cutis; 2011 May; 87(5):251-9. PubMed ID: 21699130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gel vehicles are not inherently more irritating than creams.
    Kirkland CR; Yelverton CB; Fleischer AB; Camacho FT; Feldman SR
    J Drugs Dermatol; 2006 Mar; 5(3):269-72. PubMed ID: 16573261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
    Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
    J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical overview of azelaic acid.
    Elewski B; Thiboutot D
    Cutis; 2006 Feb; 77(2 Suppl):12-6. PubMed ID: 16566283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
    Conde JF; Yelverton CB; Balkrishnan R; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2007 May; 6(5):495-8. PubMed ID: 17679183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients.
    Draelos ZD; Green BA; Edison BL
    J Cosmet Dermatol; 2006 Mar; 5(1):23-9. PubMed ID: 17173568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.